The FDA has approved Lipfendra, a once-daily oral PCSK9 inhibitor for adults with high LDL cholesterol. The pill offers an alternative to injections for patients who need further LDL reduction beyond ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results